PCN7- ECONOMIC EVALUATION OF GEMZAR AND BEST SUPPORTIVE CARE (BSC) RELATIVE TO BEST SUPPORTIVE CARE ALONE IN THE TREATMENT OF NON SMALL CELL LUNG (NSCLC) CANCER IN THE UK
Sep 1, 2001, 00:00 AM
10.1046/j.1524-4733.2001.40202-53.x
https://www.valueinhealthjournal.com/article/S1098-3015(11)71212-8/fulltext
Section Title :
Section Order :
104
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)71212-8&doi=10.1046/j.1524-4733.2001.40202-53.x